Alnylam Pharmaceuticals
ALNY
#554
Rank
HK$347.97 B
Marketcap
HK$2,608
Share price
3.38%
Change (1 day)
40.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: HK$3,847 HKD on 2025-10-20

Lowest end of day price: HK$30.94 HKD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-16.26%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
HK$1,210 0.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$367.78 0.43%๐Ÿ‡ซ๐Ÿ‡ท France
HK$5,846-0.32%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$170.65 2.88%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$63.91 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$9.16 0.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$243.96 1.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$499.59-2.07%๐Ÿ‡บ๐Ÿ‡ธ USA